» Articles » PMID: 21800002

Safety of Prothrombin Complex Concentrates for Rapid Anticoagulation Reversal of Vitamin K Antagonists. A Meta-analysis

Overview
Journal Thromb Haemost
Publisher Thieme
Date 2011 Jul 30
PMID 21800002
Citations 84
Authors
Affiliations
Soon will be listed here.
Abstract

Prothrombin complex concentrates (PCCs) are recommended as the treatment of choice in warfarin-related coagulopathy. However, the risk of thromboembolic complications associated with their use is not well defined. We performed a meta-analysis to estimate the rate of thromboembolic complications in patients receiving vitamin K antagonists (VKAs) treated with PCCs for bleeding or before urgent surgery. Medline and Embase databases were searched. Two reviewers performed study selection and extracted data independently. Studies providing data on incidence of thromboembolic complications in VKA-treated patients were eligible for the study. Weighted mean proportion of the rate of thromboembolic complications and the mortality rate were calculated. Twenty-seven studies (1,032 patients) were included. Seven studies used 3-factor, and 20 4-factor PCCs. Twelve patients had a thromboembolic complication (weighted mean 1.4%; 95% CI 0.8-2.1), of which two were fatal. The incidence of thromboembolic events was 1.8% (95% CI 1.0-3.0) in patients treated with 4-factor PCCs, and 0.7% (95% CI 0.0-2.4) in patients treated with 3-factor PCCs. Total mortality rate was 10.6% (95% CI 5.9-16.6). In conclusion, our results suggest there is a low but quantifiable risk of thromboembolism in VKA-treated patients receiving PCCs for anticoagulation reversal. These findings should be confirmed in randomised, controlled trials.

Citing Articles

Cerebral infarction following administration of andexanet alfa for anticoagulant reversal in a patient with traumatic acute subdural hematoma.

Nagai A, Karibe H, Narisawa A, Kameyama M, Ishikawa S, Iwabuchi N Surg Neurol Int. 2023; 14:286.

PMID: 37680936 PMC: 10481803. DOI: 10.25259/SNI_358_2023.


Perioperative Assessment and Optimization in Major Colorectal Surgery: Medication Management.

Kane W, Berry P Clin Colon Rectal Surg. 2023; 36(3):210-217.

PMID: 37113275 PMC: 10125279. DOI: 10.1055/s-0043-1761156.


Coagulopathy management of multiple injured patients - a comprehensive literature review of the European guideline 2019.

Niemann M, Otto E, Eder C, Youssef Y, Kaufner L, Mardian S EFORT Open Rev. 2022; 7(10):710-726.

PMID: 36287131 PMC: 9619392. DOI: 10.1530/EOR-22-0054.


Efficacy of prothrombin complex concentrate (PCC) versus fresh frozen plasma (FFP) in reducing perioperative blood loss in cardiac surgery: study protocol for a non-inferiority, randomised controlled trial.

Pei L, Sun C, Lv H, Zhang Y, Shi J BMJ Open. 2022; 12(2):e051072.

PMID: 35144945 PMC: 8845189. DOI: 10.1136/bmjopen-2021-051072.


Efficacy and safety of activated prothrombin complex concentrate for the reversal of vitamin K antagonist major bleeding.

Sheikh-Taha M, Crawley R Sci Rep. 2022; 12(1):1814.

PMID: 35110612 PMC: 8810750. DOI: 10.1038/s41598-022-05803-w.